Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative.
about
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Carbon nanotube-liposome supramolecular nanotrains for intelligent molecular-transport systems.pH-sensitive liposomes--principle and application in cancer therapy.Biodegradable nanoparticles for cytosolic delivery of therapeutics.Controlling subcellular delivery to optimize therapeutic effectDrug delivery systems: Advanced technologies potentially applicable in personalized treatments.pH-sensitive liposomes for drug delivery in cancer treatment.Fabrication of dendrimer-releasing lipidic nanoassembly for cancer drug delivery.Powering up the molecular therapy of RNA interference by novel nanoparticles.Basic concepts and recent advances in nanogels as carriers for medical applications.Fusogenic pH sensitive liposomal formulation for rapamycin: improvement of antiproliferative effect.Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes.The influence of aromatic side-chains on the aqueous properties of pH-sensitive poly(L-lysine iso-phthalamide) derivatives.Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.Alkylated derivatives of poly(ethylacrylic acid) can be inserted into preformed liposomes and trigger pH-dependent intracellular delivery of liposomal contents.Cholesterol transport from liposomal delivery vehicles.Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug deliveryNovel gene delivery systems: complexes of fusigenic polymer-modified liposomes and lipoplexes.pH-Responsive Micelle-Based Cytoplasmic Delivery System for Induction of Cellular Immunity.Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.Thermo-responsive systems for controlled drug deliveryBleomycin-Loaded pH-Sensitive Polymer–Lipid-Incorporated Liposomes for Cancer Chemotherapy
P2860
Q30366990-6955F7AA-1160-441F-874C-13528D5EBF35Q30528954-DA60F6D0-D8BB-4251-89E9-0374920E06D8Q36790100-0B2BC955-21E9-4D62-AC54-32772118486EQ36904010-207229B9-964F-4A87-98E0-5B7C7533927AQ37813021-467333DE-382E-4A7C-BDD9-D00B289B150EQ38063945-748F8D12-C5D0-42D2-BE51-9D711FCB8E18Q38136240-C6BC3598-4E72-486A-BA6D-1F2D7399C665Q38777471-469B487D-8C44-4D78-BCD1-62B064D8D559Q38843670-08DD4DF1-A5D3-4B8F-A4AA-8C3B8ACB7A5DQ38970116-1AB18EF4-4772-4244-9F2D-157103E7E731Q38985738-3C77D9EA-A732-44B9-B5B3-369F08258A7EQ39558977-4CBD8083-2D61-4BCE-ACAE-C5A4DAFC4E79Q39694936-822DE00E-9B53-4EB9-BC5C-D0B5B0D97ECBQ39836322-6FB6AE2A-5F77-451C-8414-718A9DE41DE4Q41912561-5E186FAA-5D9A-4535-ABB1-D1DC2F0F48B0Q42265489-0B824D22-D182-49F9-A8D7-6C2A661FBEC3Q42372839-AFBE2070-E906-4609-95F3-2C840C7A8A8FQ45877878-4D36D2C9-36EB-4DFE-B54C-808F9CCCEFA8Q47203536-6907F11B-1DA8-469A-9EFA-886B0C027C1CQ53203964-5AF55192-840B-4E2A-94A1-6D3A68129C3AQ57372657-9644AE82-C036-480A-9138-022FC1363722Q57383052-B62EE9FE-3976-4A77-A47A-5AF1B801AFD7
P2860
Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Cytoplasmic delivery of calcei ...... y(ethylene glycol) derivative.
@en
type
label
Cytoplasmic delivery of calcei ...... y(ethylene glycol) derivative.
@en
prefLabel
Cytoplasmic delivery of calcei ...... y(ethylene glycol) derivative.
@en
P2093
P1476
Cytoplasmic delivery of calcei ...... y(ethylene glycol) derivative.
@en
P2093
P304
P356
10.1016/S0005-2736(96)00244-1
P407
P577
1997-04-01T00:00:00Z